Scientists find new gene linked to ovarian cancer
Wednesday 4 September 2013
Cancer Research UK Press Release
Cancer Research UK scientists have found a gene in mice that could protect against ovarian cancer and, if faulty, may increase the chance of developing the disease, according to research published in Nature1.
This gene, known as Helq, helps repair any damage to DNA that happens when it is copied as cells multiply. So if the gene is missing or faulty, DNA errors could mount up, increasing the chance of cancer developing.
The team, from Cancer Research UK’s London Research Institute, found that mice without either of the two copies of the Helq gene were twice as likely to develop ovarian tumours, as well as becoming less fertile. And even losing just a single copy of the Helq gene was enough to cause a mouse to develop more tumours.
Dr Simon Boulton, senior author from Cancer Research UK’s London Research Institute, said: “Our findings show that if there are problems with the Helq gene in mice it increases the chance of them developing ovarian and other tumours. This is an exciting finding because this might also be true for women with errors in Helq, and the next step will be to see if this is the case.
“If it plays a similar role in humans, this may open up the possibility that, in the future, women could be screened for errors in the Helq gene that might increase their risk of ovarian cancer.”
Dr Julie Sharp, Cancer Research UK’s senior science information manager, said: “This study pulls together clues from a series of experiments building a picture of cell faults that could lead to ovarian cancer in women.
“Ovarian cancer can be hard to diagnose early and treat successfully so the more we know about the causes of the disease, the better equipped we will be to detect and treat it.”
In the UK around 7,000 women are diagnosed with ovarian cancer each year and around 4,300 die from the disease2.
For media enquiries please contact the press office on 020 3469 8300 or, out-of-hours, the duty press officer on 07050 264 059.
Adelman C.A., Lolo R.L., Birkbak N.J., Murina O., Matsuzaki K., Horejsi Z., Parmar K., Borel V., Skehel J.M. & Stamp G. & (2013). HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis, Nature, DOI: 10.1038/nature12565
Notes to editors
Visit our A-Z topic pages
Recent news and press releases
- Press Release: New EU legislation would halt research and put lives at risk, warns Cancer Research UK (5 Dec 2013)
- News story: Study highlights varying cancer survival rates across Europe (4 Dec 2013)
- Press Release: Prevent proteins folding and you may stop cancer growing (2 Dec 2013)
- News story: Targeting stem cell molecule blocks bowel cancer in mice (1 Dec 2013)
- Press Release: Urine test could help detect aggressive bladder cancer (29 Nov 2013)
Question about cancer? Contact our information nurse team